Pharmaceuticals

Avascular Necrosis Sector Forecast Shows Robust Momentum, Climbing to $1.38 Billion With 9.2% CAGR

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the avascular necrosis market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Avascular Necrosis Market?

The avascular necrosis market has experienced robust expansion in recent years. This market is projected to expand from $0.89 billion in 2025 to $0.97 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.5%. Historically, this expansion has been driven by factors such as trauma-related bone injuries, excessive steroid use, alcohol consumption, delayed diagnosis, and the rise in orthopedic surgeries.

The avascular necrosis market is projected to experience substantial growth over the upcoming years, reaching a valuation of $1.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This expansion during the forecast period is fueled by factors such as the increasing adoption of advanced imaging techniques, ongoing research in regenerative medicine, a growing aging population, the prevalence of sports injuries, and continuous innovation in orthopedics. Key trends anticipated within this period involve the increasing utilization of early diagnostic imaging, a rise in the adoption of joint-preserving treatments, the proliferation of minimally invasive surgical procedures, the broadening of physical rehabilitation initiatives, and an emphasis on intervening at the early stages of the disease.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

What Drivers Are Supporting Technological Adoption In The Avascular Necrosis Market?

The expansion of knee replacement and hip surgery procedures is anticipated to fuel the expansion of the avascular necrosis market. These surgical interventions are performed to substitute compromised joints and alleviate discomfort in advanced cases of avascular necrosis. The volume of these surgeries is climbing due to the increasing incidence of osteoarthritis, a condition that results in intense joint pain and mobility challenges, often necessitating surgery for relief and improved quality of life. Avascular necrosis plays a substantial role in the demand for knee replacements and hip surgeries, as it involves the demise of bone tissue due to inadequate blood supply, frequently resulting in joint decay and collapse. For instance, in November 2024, the American Joint Replacement Registry (AJRR), a US-based registry run by the American Academy of Orthopaedic Surgeons, indicated that in 2023, the number of hip and knee arthroplasty procedures captured in the registry exceeded 4 million, representing an 18% increase compared to 2022. Consequently, the growing frequency of knee replacements and hip surgeries is propelling the avascular necrosis market forward.

Avascular Necrosis Market Driver: Rising Healthcare Expenditure Fuelling The Growth Of The Market Due To Improving Diagnostics And Treatment Access

The escalating healthcare expenditure is anticipated to drive the expansion of the avascular necrosis market. Healthcare expenditure encompasses the total funds allocated to health services, treatments, and medical supplies within a given population or healthcare framework. This expenditure is on the rise primarily due to the increasing incidence of chronic diseases, which demand continuous management, frequent hospital visits, and costly pharmaceutical interventions. For avascular necrosis, increased healthcare spending is beneficial as it facilitates access to prompt diagnosis, sophisticated treatments, and surgical options, all of which contribute to managing the condition and enhancing patient recovery. For instance, in April 2025, as reported by the American Medical Association, a US-based professional association and lobbying group of physicians and medical students, health spending in the United States climbed by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per capita, surpassing the 4.6% increase observed in 2022. Consequently, the upward trend in healthcare expenditure is stimulating the growth of the avascular necrosis market.

What Segment Types Are Examined In The Avascular Necrosis Market?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Who Are The Major Companies Operating In The Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Avascular Necrosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24476&type=smp

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795